Klinikum Klagenfurt Am Wörthersee Is Live With SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am...
SOPHiA GENETICS Triumphs With AI-Driven Growth
Earnings Call Summary | Sophia Genetics(SOPH.US) Q1 2024 Earnings Conference
The following is a summary of the SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript:Financial Performance:SOPHiA GENETICS reported Q1 revenue of $15.8 million, a 13% increase from the same qu
RBC Capital Remains a Buy on SOPHiA GENETICS (SOPH)
Sophia Genetics Q1 Loss Narrows, Revenue Up
Express News | SOPHiA GENETICS Reaffirms FY24 Revenue $78M-$81M Vs $79.168M Est
Sophia Genetics | 6-K: Report of foreign private issuer (related to financial reporting)
SOPHiA GENETICS Backs 2024 View of Rev $78M-$81M >SOPH
SOPHiA GENETICS Backs 2024 View of Rev $78M-$81M >SOPH
SOPHiA GENETICS Still Sees 2024 Revenue Growth of 25%-30% >SOPH
SOPHiA GENETICS Still Sees 2024 Revenue Growth of 25%-30% >SOPH
Sophia Genetics Q1 2024 GAAP EPS $(0.21) Beats $(0.28) Estimate, Sales $15.779M Miss $16.467M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.28) by 25 percent. This is a 32.26 percent increase over losses of $(0.31)
Press Release: SOPHiA GENETICS Reports First Quarter 2024 Results
SOPHiA GENETICS Reports First Quarter 2024 Results Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) --
SOPHiA GENETICS 1Q Loss/Shr 21c >SOPH
SOPHiA GENETICS 1Q Loss/Shr 21c >SOPH
SOPHiA GENETICS (SOPH) Gets a Buy From RBC Capital
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the
Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering
Sophia Genetics (SOPH) said Tuesday that Nigeria-based Syndicate Bio has signed on to implement the medicine software company's MSK-Access laboratory platform, giving patients access to cloud-based ge
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout AfricaBOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cl
We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Express News | SOPHiA GENETICS Announced That Unilabs Is Live On The SOPHiA DDM Platform To Test For HRD-Status In Solid Tumors And Provide Expedited Analysis Across Its Network In Switzerland
RBC Capital Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)
No Data